Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas.
Waalewijn H. et al, (2025), The Lancet. Child & adolescent health, 9, 274 - 282
Dose‐Optimization of a Novel Co‐Formulated Triple Combination Antimalarial Therapy: Artemether‐Lumefantrine‐Amodiaquine
Tarning J. et al, (2025), Clinical Pharmacology & Therapeutics
Author Correction: Impact of standard and long-lasting ivermectin formulations in cattle and buffalo on wild Anopheles survival on Sumba Island, Indonesia.
Kobylinski KC. et al, (2025), Scientific reports, 15
Potential interaction between clorsulon and ivermectin for malaria vector control.
Hongsuwong T. et al, (2025), Medical and veterinary entomology
Potential of emodepside for vector-borne disease control.
Khemrattrakool P. et al, (2025), Malaria journal, 24
Inhibition of Giardia duodenalis by isocryptolepine -triazole adducts and derivatives.
Popruk S. et al, (2024), International journal for parasitology. Drugs and drug resistance, 26
Pharmacometric and statistical considerations for dose optimization
Chotsiri P. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology
Impact of standard and long-lasting ivermectin formulations in cattle and buffalo on wild Anopheles survival on Sumba Island, Indonesia.
Kobylinski KC. et al, (2024), Scientific reports, 14
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
Commons RJ. et al, (2024), The Lancet Child & Adolescent Health, 8, 798 - 808
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Chan XHS. et al, (2024), The Lancet Microbe, 101002 - 101002
Author Correction: Ivermectin metabolites reduce Anopheles survival.
Kobylinski KC. et al, (2024), Scientific reports, 14
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers.
Tarning J. et al, (2024), Malaria journal, 23
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.
Abla N. et al, (2024), Malaria journal, 23
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS medicine, 21
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever.
Ding J. et al, (2024), CPT: pharmacometrics & systems pharmacology
Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections.
Ding J. et al, (2024), CPT: pharmacometrics & systems pharmacology
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
Determination of ivermectin in plasma and whole blood using LC-MS/MS
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
Efficacy of ivermectin and its metabolites against <i>Plasmodium falciparum</i> liver stages in primary human hepatocytes.
Annamalai Subramani P. et al, (2024), Antimicrobial agents and chemotherapy, 68